Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06397677

Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease

Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease (MOUNTAIN)

Status
Recruiting
Phase
Study type
Observational
Enrollment
450 (estimated)
Sponsor
University of Colorado, Denver · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

A study to identify patients with Rheumatoid Arthritis - Associated Interstitial Lung Disease (RA-ILD) that are at the highest risk for progression. The goal of the investigators is to recruit a group of patients with RA-ILD and collect information to help us understand more about disease progression. The investigators will do this using a combination of clinical, radiologic, and biologic features.

Detailed description

The central hypothesis is that novel quantitative imaging and specific blood markers will be associated with progressive RA-ILD. The hypothesis will be tested through collection and analysis of peripheral blood, in addition to the analysis of HRCT (high-resolution computed tomography) scans performed as standard of care (clinical) on research subjects. Procedures performed: Baseline Year 0: Blood sample, buccal (cheek) swab, questionnaires and if performed clinically - Pulmonary Function tests, 6 Minute Walk Test, and HRCT scan of lungs Every 4 months (at clinic visit): Blood sample, questionnaires Year 1 and Year 2 Follow-ups: Blood sample, buccal (cheek) swab, questionnaires and if performed clinically - Pulmonary Function tests, 6 Minute Walk Test, and HRCT scan of lungs

Conditions

Interventions

TypeNameDescription
GENETICResearch Testing Performed (Laboratory)Blood collection (DNA, RNA)
DIAGNOSTIC_TESTInformation Collected as Standard of CareHigh Resolution CT Scan (Chest), Pulmonary Function Testing (PFT), 6-Minute Walk Test (6MWT)
OTHERResearch Testing PerformedBlood collection (non-genetic), Buccal Swab, Rheumatologic Assessment, Pulmonary Assessment, Questionnaires

Timeline

Start date
2024-01-22
Primary completion
2029-01-01
Completion
2034-01-01
First posted
2024-05-03
Last updated
2024-05-03

Locations

4 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT06397677. Inclusion in this directory is not an endorsement.